Search Page

1

Cite

Share

The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease.

Golzari-Sorkheh M, Brown C, Weaver DF, Reed M. Golzari-Sorkheh M, et al. Among authors: weaver df. J Alzheimers Dis. 2021 Sep 21. doi: 10.3233/JAD-210660. Online ahead of print. J Alzheimers Dis. 2021. PMID: 34569958

Cite

Share

2

Cite

Share

The N^th Wave of COVID-19: Will It Be Alzheimer's?

Weaver DF. Weaver DF. Can J Neurol Sci. 2021 Sep 23:1-9. doi: 10.1017/cjn.2021.224. Online ahead of print. Can J Neurol Sci. 2021. PMID: 34551846 No abstract available.

Cite

Share

3

Cite

Share

Trickle-Down Therapeutics: Entitlement and Deprivation in the Treatment of Alzheimer's Disease.

Weaver DF. Weaver DF. Can J Neurol Sci. 2021 Sep 6:1-3. doi: 10.1017/cjn.2021.207. Online ahead of print. Can J Neurol Sci. 2021. PMID: 34486959 No abstract available.

Cite

Share

4

Cite

Share

COVID-19 as a Trigger of Brain Autoimmunity.

Gupta M, Weaver DF. Gupta M, et al. Among authors: weaver df. ACS Chem Neurosci. 2021 Jul 21;12(14):2558-2561. doi: 10.1021/acschemneuro.1c00403. Epub 2021 Jul 2. ACS Chem Neurosci. 2021. PMID: 34213312 Free PMC article.

Cite

Share

5

Cite

Share

Drug-Receptor Interactions: It is a Numbers Game.

Meek A, Weaver DF. Meek A, et al. Among authors: weaver df. Can J Neurol Sci. 2021 Jun 29:1-2. doi: 10.1017/cjn.2021.152. Online ahead of print. Can J Neurol Sci. 2021. PMID: 34183078 No abstract available.

Cite

Share

6

Cite

Share

Ferulic acid amide derivatives with varying inhibition of amyloid-β oligomerization and fibrillization.

Kolaj I, Wang Y, Ye K, Meek A, Liyanage SI, Santos C, Weaver DF. Kolaj I, et al. Among authors: weaver df. Bioorg Med Chem. 2021 Aug 1;43:116247. doi: 10.1016/j.bmc.2021.116247. Epub 2021 Jun 6. Bioorg Med Chem. 2021. PMID: 34157569

Cite

Share

7

Cite

Share

Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease.

Wang Z, Wang Y, Pasangulapati JP, Stover KR, Liu X, Schier SW, Weaver DF. Wang Z, et al. Among authors: weaver df. Eur J Med Chem. 2021 Oct 15;222:113565. doi: 10.1016/j.ejmech.2021.113565. Epub 2021 Jun 2. Eur J Med Chem. 2021. PMID: 34118718

Cite

Share

8

Cite

Share

A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.

Zheng Y, Stafford PM, Stover KR, Mohan DC, Gupta M, Keske EC, Schiavini P, Villar L, Wu F, Kreft A, Thomas K, Raaphorst E, Pasangulapati JP, Alla SR, Sharma S, Mittapalli RR, Sagamanova I, Johnson SL, Reed MA, Weaver DF. Zheng Y, et al. Among authors: weaver df. ChemMedChem. 2021 Jul 20;16(14):2195-2205. doi: 10.1002/cmdc.202100107. Epub 2021 May 26. ChemMedChem. 2021. PMID: 33759400

Cite

Share

9

Cite

Share

Inter-individual variability in disease expression: the Tudor-Churchill spectrum.

Weaver DF. Weaver DF. Neurol Sci. 2021 Mar 3:1-5. doi: 10.1007/s10072-021-05129-x. Online ahead of print. Neurol Sci. 2021. PMID: 33660158 Free PMC article.

Cite

Share

10

Cite

Share

Furazans in Medicinal Chemistry.

Mancini RS, Barden CJ, Weaver DF, Reed MA. Mancini RS, et al. Among authors: weaver df. J Med Chem. 2021 Feb 25;64(4):1786-1815. doi: 10.1021/acs.jmedchem.0c01901. Epub 2021 Feb 11. J Med Chem. 2021. PMID: 33569941 Review.

Cite

Share